PHARMASEEK
DEAD

Serial Number

88162353

Owner

PharmaSeek, LLC

Attorney

Jessica L. Rothstein

First Use Date

Dec 31, 1994

Filing Date

Oct 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PHARMASEEK Trademark

Serial Number: 88162353 • Registration: 5906688

PHARMASEEK is a trademark filed by PharmaSeek, LLC on October 19, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

PharmaSeek, LLC

8040 Excelsior Drive, Suite 300
Madison, WI 53717

Entity Type: 16

Trademark Details

Filing Date

October 19, 2018

Registration Date

November 12, 2019

First Use Anywhere

December 31, 1994

First Use in Commerce

December 31, 2002

Published for Opposition

August 27, 2019

Cancellation Date

May 22, 2026

Goods & Services

Business consulting, management, and planning services in the field of clinical trials, namely, analyzing and reporting possible cost savings in human research study protocol development and possible cost savings in research site identification on behalf of pharmaceutical trial sponsors and contract research organizations, all for business cost management purposes; Business consulting, management, and planning services in the field of clinical trials, namely, applying business analytics to determine the appropriate payer coverage and negotiate study budgets for clinical trial sites; Business consulting in the field of clinical trial study identification on behalf of clinical trial sites; Business consulting in the field of clinical trials, namely, negotiating clinical trial budgets and business contracts on behalf of clinical trial sites; Administration, billing and reconciliation of accounts for clinical trial sites

Bill payment services; Accounts receivables financing; Financial management of reimbursement payment for clinical trial sites; and Financial management in the field of clinical trials, including accounts receivable financing and accounts payable debiting, for clinical trial sites

Filing History

CANCELLED SEC. 8 (6-YR)
May 22, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 9, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2023 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 22, 2020 ASCK
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 11, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2019 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 28, 2019 ASCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
ASSIGNED TO LIE
Jul 21, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 29, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 29, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 29, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2018 NWOS
NEW APPLICATION ENTERED
Oct 23, 2018 NWAP